Skip to content

Metabolic Effects of the Manipulation of Nutrient Sequence in the Main Meals in Type 2 Diabetic Patients

Metabolic Effects of the Manipulation of Nutrient Sequence in the Main Meals in Type 2 Diabetic Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02442024
Enrollment
20
Registered
2015-05-13
Start date
2014-01-31
Completion date
2015-12-31
Last updated
2015-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

diabetes mellitus, diet, nutrient sensing

Brief summary

The investigators aimed at evaluating the metabolic effects of the inversion of the typical Italian sequence of food ingestion at the main meals in type 2 diabetic patients.

Detailed description

An intervention group follows a modified diet over a period of two months in which the ingestion of protein and lipid happens before that of carbohydrates. A control group follows a standardized diet in which the ingestion of carbohydrates happens before that of protein and lipid. Both diets contain a reduced intake of high-glycemic index meals, saturated fatty acids, trans fatty acids and alcohol. On four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet) we measure clinical and metabolic parameters (weight, waist and hip circumferences, glucose, glycated hemoglobin, fructosamine, lipid profile) to compare the effects of the two diets.

Interventions

BEHAVIORALModified Diet

Two months of a diet in which the ingestion of protein and lipid precedes that of carbohydrates.

BEHAVIORALStandard Diet

Two months of a diet in which the ingestion of protein and lipid follows that of carbohydrates.

Sponsors

Azienda Ospedaliero, Universitaria Pisana
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Well-controlled type 2 diabetes * HbA1c 48-58 mmol/mol (6.5-7.5%) * Treatment with metformin or diet only * BMI: \< 35 kg/m\^2

Exclusion criteria

* Autoimmune diseases, neoplasia, heart, kidney, liver or respiratory failure * Pregnancy * Bariatric surgery

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline fructosamine after 1 and 2 months of dietOn four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)Fructosamine will be measured.

Secondary

MeasureTime frameDescription
Change from baseline fasting plasma glucose after 1 and 2 months of dietOn four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)Fasting plasma glucose will be measured.
Change from baseline glycated hemoglobin after 1 and 2 months of dietOn four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)Glycated hemoglobin will be measured.
Change from baseline weight after 1 and 2 months of diet adipose tissue locationOn four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)Waist circumference and hip circumference will be measured.
Change from baseline adipose tissue location after 1 and 2 months of dietOn four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)Weight, waist circumference and hip circumference will be measured.
Change from baseline lipid profile after 1 and 2 months of dietOn four days separated by one month each other (two before the beginning of the diet and two after 1 month and 2 months of diet)Lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides) will be measured.

Countries

Italy

Contacts

Primary ContactAndrea Natali, Professor
andrea.natali@med.unipi.it+39050992814
Backup ContactDomenico Trico, Dr
domenico.trico@for.unipi.it+39050993640

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026